Skip to content
Answers from the Lab cover art

All episodes

Answers from the Lab, 392 episodes. Page 2 of 4.

#
Title
101

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

102

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

103

Tick Season Outlook: Elitza Theel, Ph.D.

104

Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.

105

Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.

106

Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

107

Why Measles Is on the Rise: Matthew Binnicker, Ph.D.

108

Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

109

Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.

110

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

111

Syphilis Testing Updates: Elitza Theel, Ph.D.

112

Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.

113

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.

114

Black History Month: Bill Morice, M.D., Ph.D.

115

Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.

116

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.

117

Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.

118

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.

119

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

120

The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.

121

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.

122

Evolution of Syphilis: Elitza Theel, Ph.D.

123

A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.

124

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

125

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.

126

Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC

127

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.

128

The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.

129

Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.

130

Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

131

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.

132

Comments on the FDA’s Proposed Rule: Bill Morice, M.D., Ph.D.

133

Protecting Against Winter Respiratory Viruses: Bill Morice, M.D., Ph.D.

134

Congressional and Federal Updates: Bill Morice, M.D., Ph.D.

135

Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D.

136

RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.

137

Safeguards for AI in Healthcare: Bill Morice, M.D., Ph.D.

138

A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

139

Opportunities Around At-Home Testing: Bill Morice, M.D., Ph.D.

140

How AI Can Add Value to Laboratory Medicine: Bill Morice, M.D., Ph.D.

141

Transformative Technologies: Bill Morice, M.D., Ph.D.

142

Proposed Regulations for Laboratory Developed Tests: Bill Morice, M.D., Ph.D.

143

Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D.

144

Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D.

145

What to Know About Leprosy: Nancy Wengenack, Ph.D.

146

Flea-borne Typhus: Elitza Theel, Ph.D.

147

Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D.

148

Summertime Pathogens: Bill Morice, M.D., Ph.D.

149

Modern-day Outbreaks: Bill Morice, M.D., Ph.D.

150

Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D.

151

Learning Through Teaching Global Health: Bill Morice, M.D., Ph.D.

152

Panel pinpoints causes of genetic hearing loss: Nicole Boczek, Ph.D., and Melanie Meyer, M.S, CGC

153

Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D.

154

Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

155

Dengue and Chikungunya Outbreaks: Elitza Theel, Ph.D.

156

Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

157

Malaria in the United States: Bill Morice, M.D., Ph.D.

158

Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

159

The Latest on Measles: Matthew Binnicker, Ph.D.

160

Results report simplifies urine test interpretation: John Lieske, M.D.

161

FDA Oversight of Lab-Developed Tests: Bill Morice, M.D., Ph.D.

162

Multigene panel provides efficient ataxia diagnosis: Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC

163

Remote Diagnostics: Bill Morice, M.D., Ph.D.

164

Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D.

165

Diagnosing Lyme Disease: Bill Morice, M.D., Ph.D.

166

BioPharma Diagnostics: Bill Morice, M.D., Ph.D.

167

The impact of AI: Bill Morice, M.D., Ph.D.

168

West Nile virus: Elitza Theel, Ph.D.

169

The progression of the diagnostic landscape: Bill Morice, M.D., Ph.D.

170

Endemic fungal infections in North America: Elitza Theel, Ph.D.

171

A strong community of lab professionals: Bill Morice, M.D., Ph.D., and Susan Van Meter

172

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D.

173

Emerging fungal pathogens: Dr. Nancy Wengenack

174

Leading important industry conversations: Bill Morice, M.D., Ph.D.

175

IDH assay facilitates timelier leukemia treatment: Rong He, M.D.

176

Neurofilament light chain: Bjorn Oskarsson, M.D.

177

Approaching tick season: Bill Morice, M.D., Ph.D.

178

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D.

179

Avian influenza and reflecting on three years of COVID-19: Matthew Binnicker, Ph.D.

180

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D.

181

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D.

182

Amplifying the voice of the lab during policymaking: Dr. Bill Morice

183

Whole genome sequencing streamlines diagnosis: Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC

184

Rising rates of group A streptococcus and antibiotic resistant gonorrhea: Dr. Robin Patel

185

Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.

186

When to test for norovirus: Dr. Bill Morice

187

THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.

188

Sharing Mayo Clinic knowledge globally while learning from other cultures: Dr. Bill Morice

189

Novel biomarkers added to movement disorders profile: Andrew McKeon, M.B., B.Ch., M.D.

190

How digital pathology is changing patient care at Mayo Clinic: Dr. Joaquin Garcia

191

New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.

192

Triple-demic update and the future of at-home testing: Dr. Bill Morice

193

Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice

194

Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

195

Legislative update and at-home testing: Dr. Bill Morice

196

Why cancer death rates are declining: Dr. Ansell

197

Respiratory virus update and a new measles test: Dr. Matthew Binnicker

198

Predictions for 2023: Dr. Bill Morice

199

The laboratory’s role in spurring innovation: Dr. Bill Morice

200

Respiratory illness updates and health care economics: Dr. Bill Morice